Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

NPY receptor ligands claimed by Agouron

May 25, 1998

Muse approved in South Africa

May 25, 1998

Thienopyridines for impotence, heart failure in development at Merck KGaA

May 22, 1998

Glaxo Wellcome to distribute Cortecs' Macritonin in Greece

May 22, 1998

Heterocyclic cholesterol biosynthesis inhibitors discovered at Zeneca

May 21, 1998

Somatostatin analogue launched in U.K.

May 19, 1998

Zonagen, Schering AG to drop contraceptive vaccine collaboration

May 18, 1998

Palatin finalizes license for erectile dysfunction product

May 18, 1998

Muse approved in Sweden

May 18, 1998

Oxygent research agreement restructured

May 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...